Galil Medical, a global leader in minimally invasive cryotherapy cancer treatments, announced today that they are a key supporter of the upcoming AUA course on tissue ablation, to be held in Miami on November 12-13, 2010.

Galil Medical, a global leader in minimally invasive cryotherapy cancer treatments, announced today that Columbia University Medical Center enrolled their first TRACE Registry patient.   The TRACE (Tracking Renal Tumors After Cryoablation Evaluation) Registry will allow physicians and the company to follow and evaluate the use and effectiveness of cryotherapy treatment for patients with renal masses.

Galil Medical, a global leader in minimally invasive cryotherapy treatments for cancers and other disorders, announced today that it is establishing its new Global Headquarters in Minneapolis, MN. The company is expected to open this new facility in Arden Hills during the fourth quarter of 2009.

IRVINE, CA and YOKNEAM, ISRAEL (July 7, 2009)…Endocare, Inc. (NASDAQ: ENDO) and privately-held Galil Medical Ltd., today announced that they have entered into a settlement agreement stipulating to termination of the previously announced merger agreement between Endocare and Galil Medical pursuant to which Endocare would have acquired Galil Medical, and the settlement of all related litigation in Delaware Chancery Court.

Galil Asks Delaware Chancery Court To Enjoin HealthTronics' Tender Offer For Endocare.

YOKNEAM, Israel and PLYMOUTH MEETING, Pa., June 22 /PRNewswire/ -- Galil Medical Ltd., a global cryotherapy company, filed suit against HealthTronics, Inc., late yesterday in Delaware Chancery Court, asking the Court to enjoin HealthTronics from further interfering with a merger agreement between Galil and Endocare, Inc., and to order that HealthTronics pay damages to Galil for the harm it has suffered as a result of HealthTronics' tortious interference with Galil's rights under that agreement.

Law360, New York (June 12, 2009) -- In a bid to save its merger agreement with Endocare Inc., medical device maker Galil Medical Ltd. has filed a lawsuit to block Endocare from combining with another company, Healthtronics Inc., in a battle that has also sparked a war of words between commissioners at the Federal Trade Commission.

YOKNEAM, Israel and PLYMOUTH MEETING, Pa., June 11 /PRNewswire/ -- Galil Medical Inc., a global cryotherapy company, announced today that it has filed suit in Delaware court to enjoin the proposed acquisition of Endocare, Inc. by HealthTronics, Inc. Further, Galil has asked the court to enforce the merger agreement between Galil and Endocare.

Combined Company to Expand Cryoablation Clinical Programs and Broaden Global Business Presence

IRVINE, CA, and YOKNEAM, ISRAEL (November 10, 2008) Endocare, Inc. (NASDAQ: ENDO) and privately held Galil Medical Ltd., both innovative medical device companies, today announced the signing of a definitive merger agreement. The combined company will be focused on the promotion and development of cryoablation, a minimally invasive method to freeze and destroy cancerous tumors. The transaction, which is expected to close in the first quarter of 2009, will combine the complementary clinical, technological and marketing strengths of the two companies.

Kidney cancer patients are being offered new hope of a cure with a treatment that kills tumours by freezing them. Article features Consultant urologist, Francis Keeley and appeared on BBC News.

Each year nearly 33,000 men in the UK are diagnosed with prostate cancer and more than 10,000 die from the disease. It has become the most common cancer in men and mainly affects men over the age of 50. People affected and their families should be informed about all the options available to them – cryotherapy is one such treatment option.